Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

MRNA holding history

Moderna, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings

Shares (Q2 2026)
1,035,126
Value
$72.5M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MRNA by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,035,126$72.5M<0.1%+102,857+11.0%AddedHolders
Q1 2026932,269$47.4M<0.1%−610,188−39.6%ReducedHolders
Q4 20251,542,457$45.5M<0.1%−473,371−23.5%ReducedHolders
Q3 20252,015,828$52.1M<0.1%−171,399−7.8%ReducedHolders
Q2 20252,187,227$60.3M<0.1%+763,450+53.6%AddedHolders
Q1 20251,423,777$40.4M<0.1%+227,838+19.1%AddedHolders
Q4 20241,195,939$49.7M<0.1%−336,873−22.0%ReducedHolders
Q3 20241,532,812$102.4M<0.1%+193,059+14.4%AddedHolders
Q2 20241,339,753$159.1M0.1%+146,856+12.3%AddedHolders
Q1 20241,192,897$127.1M0.1%+84,733+7.6%AddedHolders
Q4 20231,108,164$110.2M0.1%+163,264+17.3%AddedHolders
Q3 2023944,900$97.6M0.1%+34,008+3.7%AddedHolders
Q2 2023910,892$110.7M0.1%+256,295+39.2%AddedHolders
Q1 2023654,597$100.5M0.1%−813,653−55.4%ReducedHolders
Q4 20221,468,250$263.7M0.2%−120,454−7.6%ReducedHolders
Q3 20221,588,704$187.9M0.2%+399,454+33.6%AddedHolders
Q2 20221,189,250$169.9M0.2%−124,917−9.5%ReducedHolders
Q1 20221,314,167$226.4M0.2%−1,987,952−60.2%ReducedHolders
Q4 20213,302,119$838.7M0.5%+2,047,118+163.1%AddedHolders
Q3 20211,255,001$483.0M0.3%+657,299+110.0%AddedHolders
Q2 2021597,702$140.4M0.1%+185,034+44.8%AddedHolders
Q1 2021412,668$54.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.